# BBIO PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/BBIO
Company: BridgeBio

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with BBIO.

## BBIO PDUFA Milestones

- 2024-11-22 — FDA Approval — FDA approved application. FDA recorded approval of ATTRUBY on November 22, 2024. This list-only historical record is sourced from the official FDA applicatio...
  Company: BridgeBio
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540
  Event detail: https://biopharmsignal.com/pdufa-calendar/BBIO/attruby-nda-216540-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/november (November 2024)

## Related Pages

- Company page: https://biopharmsignal.com/company/BBIO
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the BBIO PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with BBIO, including decision dates, application stage, and summary details when available.
### Where can I find more context for BBIO?

Use the BioPharmSignal company page for BBIO to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.